BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31371347)

  • 1. Functional analysis of clinical
    Toh MR; Chong ST; Chan SH; Low CE; Ishak NDB; Lim JQ; Courtney E; Ngeow J
    Cold Spring Harb Mol Case Stud; 2019 Aug; 5(4):. PubMed ID: 31371347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent incidence of BARD1-truncating mutations in germline DNA from triple-negative breast cancer patients.
    De Brakeleer S; De Grève J; Desmedt C; Joris S; Sotiriou C; Piccart M; Pauwels I; Teugels E
    Clin Genet; 2016 Mar; 89(3):336-40. PubMed ID: 26010302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BARD1 translocation to mitochondria correlates with Bax oligomerization, loss of mitochondrial membrane potential, and apoptosis.
    Tembe V; Henderson BR
    J Biol Chem; 2007 Jul; 282(28):20513-22. PubMed ID: 17510055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline mutations of the BRCA1-associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations.
    Ghimenti C; Sensi E; Presciuttini S; Brunetti IM; Conte P; Bevilacqua G; Caligo MA
    Genes Chromosomes Cancer; 2002 Mar; 33(3):235-42. PubMed ID: 11807980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer.
    Weber-Lassalle N; Borde J; Weber-Lassalle K; Horváth J; Niederacher D; Arnold N; Kaulfuß S; Ernst C; Paul VG; Honisch E; Klaschik K; Volk AE; Kubisch C; Rapp S; Lichey N; Altmüller J; Lepkes L; Pohl-Rescigno E; Thiele H; Nürnberg P; Larsen M; Richters L; Rhiem K; Wappenschmidt B; Engel C; Meindl A; Schmutzler RK; Hahnen E; Hauke J
    Breast Cancer Res; 2019 Apr; 21(1):55. PubMed ID: 31036035
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Rofes P; Del Valle J; Torres-Esquius S; Feliubadaló L; Stradella A; Moreno-Cabrera JM; López-Doriga A; Munté E; De Cid R; Campos O; Cuesta R; Teulé Á; Grau È; Sanz J; Capellá G; Díez O; Brunet J; Balmaña J; Lázaro C
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33498765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apparent regional differences in the spectrum of BARD1 pathogenic variants in Spanish population and importance of copy number variants.
    Benito-Sánchez B; Barroso A; Fernández V; Mercadillo F; Núñez-Torres R; Pita G; Pombo L; Morales-Chamorro R; Cano-Cano JM; Urioste M; González-Neira A; Osorio A
    Sci Rep; 2022 May; 12(1):8547. PubMed ID: 35595798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1 and BARD1 colocalize mainly in the cytoplasm of breast cancer tumors, and their isoforms show differential expression.
    Wiener D; Gajardo-Meneses P; Ortega-Hernández V; Herrera-Cares C; Díaz S; Fernández W; Cornejo V; Gamboa J; Tapia T; Alvarez C; Carvallo P
    Breast Cancer Res Treat; 2015 Oct; 153(3):669-78. PubMed ID: 26395808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis.
    Wu JY; Vlastos AT; Pelte MF; Caligo MA; Bianco A; Krause KH; Laurent GJ; Irminger-Finger I
    Int J Cancer; 2006 Mar; 118(5):1215-26. PubMed ID: 16152612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of BARD1 missense variants in homology-directed repair and damage sensitivity.
    Adamovich AI; Banerjee T; Wingo M; Duncan K; Ning J; Martins Rodrigues F; Huang KL; Lee C; Chen F; Ding L; Parvin JD
    PLoS Genet; 2019 Mar; 15(3):e1008049. PubMed ID: 30925164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Literature Review of
    Alenezi WM; Fierheller CT; Recio N; Tonin PN
    Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32726901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: enrichment in familial BRCA1/BRCA2 mutation-negative breast cancer but not in other malignancies.
    Karppinen SM; Barkardottir RB; Backenhorn K; Sydenham T; Syrjäkoski K; Schleutker J; Ikonen T; Pylkäs K; Rapakko K; Erkko H; Johannesdottir G; Gerdes AM; Thomassen M; Agnarsson BA; Grip M; Kallioniemi A; Kere J; Aaltonen LA; Arason A; Møller P; Kruse TA; Borg A; Winqvist R
    J Med Genet; 2006 Nov; 43(11):856-62. PubMed ID: 16825437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention.
    Fabbro M; Schuechner S; Au WW; Henderson BR
    Exp Cell Res; 2004 Aug; 298(2):661-73. PubMed ID: 15265711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer predisposing BARD1 mutations in breast-ovarian cancer families.
    Ratajska M; Antoszewska E; Piskorz A; Brozek I; Borg Å; Kusmierek H; Biernat W; Limon J
    Breast Cancer Res Treat; 2012 Jan; 131(1):89-97. PubMed ID: 21344236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural requirements for the BARD1 tumor suppressor in chromosomal stability and homology-directed DNA repair.
    Laufer M; Nandula SV; Modi AP; Wang S; Jasin M; Murty VV; Ludwig T; Baer R
    J Biol Chem; 2007 Nov; 282(47):34325-33. PubMed ID: 17848578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The BRCA1/BARD1 ubiquitin ligase and its substrates.
    Witus SR; Stewart MD; Klevit RE
    Biochem J; 2021 Sep; 478(18):3467-3483. PubMed ID: 34591954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trans-activation-based risk assessment of BRCA1 BRCT variants with unknown clinical significance.
    Langerud J; Jarhelle E; Van Ghelue M; Ariansen SL; Iversen N
    Hum Genomics; 2018 Nov; 12(1):51. PubMed ID: 30458859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of missense alterations in the BRCA1 associated RING domain (BARD1) gene in breast and ovarian cancer.
    Sauer MK; Andrulis IL
    J Med Genet; 2005 Aug; 42(8):633-8. PubMed ID: 16061562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Analysis of BARD1 Missense Variants in Homology-Directed Repair of DNA Double Strand Breaks.
    Lee C; Banerjee T; Gillespie J; Ceravolo A; Parvinsmith MR; Starita LM; Fields S; Toland AE; Parvin JD
    Hum Mutat; 2015 Dec; 36(12):1205-14. PubMed ID: 26350354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BARD1 is necessary for ubiquitylation of nucleosomal histone H2A and for transcriptional regulation of estrogen metabolism genes.
    Stewart MD; Zelin E; Dhall A; Walsh T; Upadhyay E; Corn JE; Chatterjee C; King MC; Klevit RE
    Proc Natl Acad Sci U S A; 2018 Feb; 115(6):1316-1321. PubMed ID: 29367421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.